News
Becton Dickinson and Co Faces a Rough Comparator
Becton, Dickinson (NYSE: BDX) reported a small drop in revenue and a substantial loss in its third fiscal quarter, but both issues are easily explainable as long as you don't mind ignoring GAAP, which
Illumina Introduces a New Genomic Era
Illumina's (NASDAQ: ILMN) second-quarter earnings crushed expectations last week. Investors cheered the company's raised guidance, and the stock is up more than 15% since the report.Illumina's genomic
Why Amedisys Shares Slumped 24.6% in July
Amedisys Inc. (NASDAQ: AMED) shares lost nearly 25% of their value last month, according to S&P Global Market Intelligence. The drop was caused by word that the the federal government's Centers for
Why Tenet Healthcare Shares Dropped 14.4% Today
After reporting second-quarter earnings and offering up guidance for 2017, shares of Tenet Healthcare (NYSE: THC) have fallen 14.6% as of 2:30 p.m. EDT on Tuesday.Tenet Healthcare's year-over-year
Why Avis Budget Group, Depomed, and Tenet Healthcare Slumped Today
Investors saw the end of a historic bullish streak for stocks on Tuesday, as the Dow Jones Industrials failed in their bid for a 10th straight day of record-setting gains. Instead, major benchmarks
Synergy Pharmaceuticals Inc. Tanked 14.2% in July -- but Why?
Synergy Pharmaceuticals (NASDAQ: SGYP), a commercial-stage biopharma focused on gastrointestinal diseases, fell more than 14% in July, according to data from S&P Global Market Intelligence. However
Why Evolent Health, Inc. Is Plunging Today
In response to reporting second-quarter earnings and announcing a common stock offering, shares of Evolent Health (NYSE: EVH), a fast-growing digital health technology company that offers a
Why Align Technology's Shares Soared 11.4% In July
After Align Technology (NASDAQ: ALGN) reported case shipments had notched another quarterly increase, the company's shares climbed 11.4% in July, according to S&P Global Market Intelligence. Growing
Buyout Bid Overshadows NxStage Medical's Losses
Dialysis patients know how inconvenient it can be to make time for their treatments, and NxStage Medical (NASDAQ: NXTM) has sought to make dialysis much less of a burden through its home dialysis
What's Behind Pacific Biosciences of California's Stock Rally Today?
Shares of Pacific Biosciences of California (NASDAQ: PACB) are on the rise again. This is the third trading session in a row that the stock has marched upwards since announcing record revenues and a
Why NxStage Medical, Inc. Is Skyrocketing Today
Shares of NxStage Medical (NASDAQ: NXTM), a medical device maker focused on end-stage renal disease and acute kidney failure, jumped 28% as of 11:40 a.m. EDT on Monday.NxStage Medical reported its
Is Illumina Stock a Buy at Nearly 40 Times Earnings? 1 Analyst Thinks So
Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more. But do these analysts even know what they're talking about? Today, we're taking one
Here's Why Mazor Robotics Ltd. Gained 20% in July
Shares of robot-assisted surgery start-up Mazor Robotics Ltd. (NASDAQ: MZOR) gained 20% in July, according to data from S&P Global Market Intelligence. The market boosted the stock in response to news
Better Buy: Intuitive Surgical, Inc. vs. Medtronic plc
Investing in medical device companies can be ridiculously profitable.Since their respective IPOs, shares of Intuitive Surgical (NASDAQ: ISRG) -- maker of the daVinci robotic surgical system -- and
VISIOMED GROUP : Emission d'OCA pour 1,0 M EUR dans le cadre du programme d'OCABSA
VISIOMED GROUP (FR0011067669 – ALVMG), société spécialisée dans l'électronique médicale nouvelle génération, annonce le tirage, le 4 août 2017, d'une tranche d'OCABSA dans le cadre du contrat....
Insulet Delivers 26% Revenue Growth and Raises 2017 Guidance; Stock Pumps Up 7%
Insulet (NASDAQ: PODD) reported second-quarter 2017 earnings after the market closed on Thursday. The drug-delivery company, which is a leader in tubeless insulin pump technology with its Omnipod
Down 9.8%: Is Masimo Corporation Stock a Contrarian Buy?
Masimo Corporation (NASDAQ: MASI), a mid-cap medical technology company, reported stronger-than-expected second-quarter results after the bell Wednesday, but investors still decided to hit the exits
Illumina vs. Intuitive Surgical: Which Company Reported Better Earnings?
Illumina (NASDAQ: ILMN) and Intuitive Surgical (NASDAQ: ISRG) recently reported second-quarter earnings that were better than industry watchers' forecasts. These two game-changing healthcare companies
Here's Why Pacific Biosciences of California Is Surging Today
Shares of Pacific Biosciences of California (NASDAQ: PACB), a purveyor of high-accuracy genomic sequencing kits, is marching higher after reporting second-quarter earnings and a big order from a
BASTIDE : Nombre d'actions et de droits de vote au 31 juillet 2017
BASTIDE LE CONFORT MEDICAL
Société Anonyme au capital de 3.303.261 euros
Siège social : 12 avenue de la Dame, Zone Euro 2000
30132 Caissargues
RCS de NIMES N° B 305 635 039
DROITS DE....
Here's Why Teva Pharmaceutical Industries Ltd (ADR) Is Sinking Like a Stone
In response to reporting rough second-quarter results, shares of Teva Pharmaceutical Industries (NYSE: TEVA), a leading provider of generic drugs, dropped 24% as of 1:15 p.m. EDT on Thursday.Here's a
MEDICREA : Declaration_des_droits_de_vote_AMF_31-07-2017
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D'ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL
(Article L.233-8-II du Code de Commerce et Article 222-12-5 du règlement général de....
Why OraSure Technologies, Inc. Jumped Higher Today
OraSure Technologies (NASDAQ: OSUR) is up 16.5% at 12:08 p.m. EDT after reporting stellar second-quarter earnings Wednesday afternoon.Revenue was up 28% year over year. More impressively, there was a
Why Wright Medical Group Shares Are Spiking Higher Today
Shares of Wright Medical Group (NASDAQ: WMGI) were trading 10% higher earlier today after management reported second-quarter financial results that outpaced industry watchers' forecasts.Wright Medical
Here's What's Pressuring Glaukos Corp Stock Today
Shares of Glaukos Corp (NYSE: GKOS), a medical technology company focused on glaucoma treatment, were down about 9.8% as of 11:46 a.m. on Thursday in response to a second-quarter earnings report